-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $62

Benzinga·12/26/2025 10:58:56
語音播報
HC Wainwright & Co. analyst Emily Bodnar maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $48 to $62.